Compass Therapeutics, Inc.CMPXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+20.5%
5Y CAGR+21.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+20.5%/yr
vs +2.1%/yr prior
5Y CAGR
+21.2%/yr
Consistent
Acceleration
+18.4pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $72.84M | +26.7% |
| 2024 | $57.48M | +14.1% |
| 2023 | $50.36M | +20.9% |
| 2022 | $41.66M | -49.1% |
| 2021 | $81.88M | +194.4% |
| 2020 | $27.81M | -18.3% |
| 2019 | $34.05M | -11.1% |
| 2018 | $38.31M | - |